Clal Insurance’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Clal Insurance's VRTX Position: Q3 2026 in Review
Clal Insurance reduced its Vertex Pharmaceuticals (VRTX) stake by 93% in Q3 2026, selling an estimated $962K and leaving 141 shares worth $74K. The position accounts for ﹤0.01% of the portfolio, ranked #140.
Clal Insurance first reported a position in VRTX in Q2 2021 and has held it in 15 quarters since. The position peaked at $106M in Q4 2021. 1,797 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.
- Clal Insurance held 141 shares of Vertex Pharmaceuticals worth $74K as of Q3 2026.
- Clal Insurance sold 1,878 Vertex Pharmaceuticals shares in Q3 2026, an estimated $962K.
- Vertex Pharmaceuticals made up ﹤0.01% of Clal Insurance's portfolio in Q3 2026, its #140 holding.
- Clal Insurance first reported a position in Vertex Pharmaceuticals in Q2 2021 and has held it in 15 quarters since.
- Clal Insurance's Vertex Pharmaceuticals position peaked at $106M in Q4 2021.
- 1,797 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.
Based on Clal Insurance's 13F filing for Q3 2026, filed 12 Nov 2026.